Report cover image

Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 190 Pages
SKU # IRE18436368

Description

Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2024-2030


The Blood Lancet Market size was estimated at USD 1.84 billion in 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 11.09% to reach USD 3.85 billion by 2030.

Global Blood Lancet Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Lancet Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Lancet Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Lancet Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, AMBISEA Technology Corp., Ltd., Amkay Products Pvt. Ltd., B. Braun Melsungen AG, Becton, Dickinson & Company, BioCare Corporation, CML Biotech Ltd., F. Hoffmann-La Roche AG, FL MEDICAL s.r.l., Haemonetics Corporation, Improve Medical, Natus Medical by ARCHIMED, Nipro Medical Corporation, Owen Mumford Ltd., SARSTEDT AG & Co. KG, Shandong Lianfa Medical Plastic Products Co., Ltd., SteriLance Medical (Suzhou) Inc., Terumo Corporation, and Ypsome AD.

Market Segmentation & Coverage



This research report categorizes the Blood Lancet Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Home Care Lancet
Safety Lancets
Manually
Pressure Activated
Standard Lancets
Gauze Size
22G
31 G
Above 38 G
Below
Age Group
Adult
Pediatrics
End-Users
Blood Banks
Home Care
Hospitals & Clinics
Application
Cholesterol Testing
Glucose Testing
Hemoglobin Testing
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Lancet Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Lancet Market?
3. What are the technology trends and regulatory frameworks in the Blood Lancet Market?
4. What is the market share of the leading vendors in the Blood Lancet Market?
5. Which modes and strategic moves are suitable for entering the Blood Lancet Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

190 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Blood Lancet Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of diabetes among individuals and need for enhanced care
5.1.1.2. High availability of lancet through online distribution channels
5.1.1.3. Government initiatives in diabetes check up campaigns
5.1.2. Restraints
5.1.2.1. Inaccuracy in skin puncture and safety issues associated with lancet
5.1.3. Opportunities
5.1.3.1. Innovations of technologically advanced lancet devices
5.1.3.2. Rapid adoption of home based healthcare and telemedicine
5.1.4. Challenges
5.1.4.1. Stringent government regulations associated with lancet use and marketing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Blood Lancet Market, by Type
6.1. Introduction
6.2. Home Care Lancet
6.3. Safety Lancets
6.4.1. Manually
6.4.2. Pressure Activated
6.4. Standard Lancets
7. Blood Lancet Market, by Gauze Size
7.1. Introduction
7.2. 22G
7.3. 31 G
7.4. Above 38 G
7.5. Below
8. Blood Lancet Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Pediatrics
9. Blood Lancet Market, by End-Users
9.1. Introduction
9.2. Blood Banks
9.3. Home Care
9.4. Hospitals & Clinics
10. Blood Lancet Market, by Application
10.1. Introduction
10.2. Cholesterol Testing
10.3. Glucose Testing
10.4. Hemoglobin Testing
11. Americas Blood Lancet Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Blood Lancet Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Blood Lancet Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. ACON Laboratories, Inc.
15.1.3. AdvaCare Pharma
15.1.4. AMBISEA Technology Corp., Ltd.
15.1.5. Amkay Products Pvt. Ltd.
15.1.6. B. Braun Melsungen AG
15.1.7. Becton, Dickinson & Company
15.1.8. BioCare Corporation
15.1.9. CML Biotech Ltd.
15.1.10. F. Hoffmann-La Roche AG
15.1.11. FL MEDICAL s.r.l.
15.1.12. Haemonetics Corporation
15.1.13. Improve Medical
15.1.14. Natus Medical by ARCHIMED
15.1.15. Nipro Medical Corporation
15.1.16. Owen Mumford Ltd.
15.1.17. SARSTEDT AG & Co. KG
15.1.18. Shandong Lianfa Medical Plastic Products Co., Ltd.
15.1.19. SteriLance Medical (Suzhou) Inc.
15.1.20. Terumo Corporation
15.1.21. Ypsome AD
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. BLOOD LANCET MARKET RESEARCH PROCESS
FIGURE 2. BLOOD LANCET MARKET SIZE, 2023 VS 2030
FIGURE 3. BLOOD LANCET MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BLOOD LANCET MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BLOOD LANCET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BLOOD LANCET MARKET DYNAMICS
FIGURE 7. BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2030 (%)
FIGURE 10. BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BLOOD LANCET MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. BLOOD LANCET MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us